Neurotrophic and growth factor gene expression profiling of mouse bone marrow stromal cells induced by ischemic brain extracts
Open accessThe DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Treatment of rodents after stroke with bone marrow stromal cells (BMSCs) improves functional outcome. However, the mechanisms underlying this benefit have not been ascertained. This study focused on the contribution of neurotrophic and growth factors produced by BMSCs to therapeutic benefit. Rats were subjected to middle cerebral artery occlusion and the ischemic brain extract supernatant was collected to prepare the conditioned medium. The counterpart normal brain extract from non‐ischemic rats was employed as the experimental control. Using microarray assay, we measured the changes of the neurotrophin associated gene expression profile in BMSCs cultured in different media. Furthermore, real‐time RT‐PCR and fluorescent immunocytochemistry were utilized to validate the gene changes. The morphology of BMSCs, cultured in the ischemic brain‐conditioned medium for 12 h, was dramatically altered from a polygonal and flat appearance to a fibroblast‐like long and thin cell appearance, compared to those in the normal brain‐conditioned medium and the serum replacement medium. Forty‐four neurotrophin‐associated genes in BMSCs were identified by microarray assay under all three culture media. Twelve out of the 44 genes (7 neurotrophic and growth factor genes, 5 receptor genes) increased in BMSCs cultured in the ischemic brain‐conditioned medium compared to the normal brain‐conditioned medium. Real time RT‐PCR and immunocytochemistry validated that the ischemic brain‐conditioned medium significantly increased 6/7 neurotrophic and growth factor genes, compared with the normal brain‐conditioned medium. These six genes consisted of fibroblast growth factor 2, insulin‐like growth factor 1, vascular endothelial growth factor A, nerve growth factor beta, brain‐derived neurotrophic factor and epidermal growth factor. Our results indicate that transplanted BMSCs may work as ‘small molecular factories’ by secreting neurotrophins, growth factors and other supportive substances after stroke, which may produce therapeutic benefits in the ischemic brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mesenchymal stem cells as trophic mediators
Caplan, A. I., & Dennis, J. E. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20886 · Cited by 2,992 · cited 1×
“Interestingly, the pattern and quantity of such functional secretion of BMSCs could be changed in response to their existing microenvironment.(17) BMSCs in ischemic conditions increase the synthesis of some cytokines and growth factors.”
BackgroundVEGF enhances angiogenesis and promotes blood–brain barrier leakage in the ischemic brain
Zhang, Z. G., Zhang, L., Jiang, Q., Zhang, R., Davies, K., Powers, C., Bruggen, N. V., & Chopp, M. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9369 · Cited by 1,296 · cited 2×
“Exogenous VEGF, administered pharmacologically or genetically, reduces infarct size and apoptosis, improves neurological performance and enhances the survival of newborn neurons(35) and after stroke in the adult.(34) IGF1 is a neurotrophic polypeptide that improves somatosensory function by reducing the size of cortic…”
BackgroundSelf-citationNerve Growth Factor Signaling, Neuroprotection, and Neural Repair
Sofroniew, M. V., Howe, C. L., & Mobley, W. C. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.1217 · Cited by 1,284 · cited 1×
“NGF/Trk A is neuroprotective following various forms of brain injury.(8,29) EGF is a polypeptide involved in directed cell migration(30) and connexin 43 gap junction communications.”
BackgroundVEGF-induced neuroprotection, neurogenesis, and angiogenesis after focal cerebral ischemia
Sun, Y., Jin, K., Xie, L., Childs, J., Mao, X. O., Logvinova, A., & Greenberg, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200317977 · Cited by 1,189
Sairanen, M., Lucas, G., Ernfors, P., Castrén, M., & Castrén, E. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3741-04.2005 · Cited by 763
Therapeutic benefit of bone marrow stromal cells administered 1 month after stroke
Shen, L. H., Li, Y., Chen, J., Zacharek, A., Gao, Q., Kapke, A., Lu, M., Raginski, K., Vanguri, P., Smith, A., et al. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600311 · Cited by 353
Self-citation
Cited by
Exosomes/miRNAs as mediating cell-based therapy of stroke
Xin, H., Li, Y., & Chopp, M. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00377 · Cited by 297
Self-citationvan Velthoven, C. T. J., Kavelaars, A., van Bel, F., & Heijnen, C. J. (2010) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2009.10.017 · Cited by 252
Marrow stromal cell transplantation in stroke and traumatic brain injury
Li, Y., & Chopp, M. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2008.03.096 · Cited by 222
“Using microarray assay, we measured the changes of the neurotrophin associated gene expression profile in MSCs cultured in the ischemic brain-conditioned medium [37].”
Self-citationNasal administration of stem cells: a promising novel route to treat neonatal ischemic brain damage
van Velthoven, C. T. J., Kavelaars, A., van Bel, F., & Heijnen, C. J. (2010) · Pediatric Research · doi:10.1203/pdr.0b013e3181f1c289 · Cited by 174
Liu, Z., Li, Y., Zhang, X., Savant-Bhonsale, S., & Chopp, M. (2008) · Stroke · doi:10.1161/strokeaha.107.511659 · Cited by 115
Self-citation
Metadata
- Authors
- Qu, R., Li, Y., Gao, Q., Shen, L., Zhang, J., Liu, Z., Chen, X., & Chopp, M.
- Venue
- Neuropathology
- Publisher
- Wiley
- Published
- 2007-07-19
- Volume
- 27
- Issue
- 4
- Pages
- 355-363
- ISSN
- 0919-6544 (ISSN-L)
- 1440-1789
- OpenAlex
- W2026609935
- Cited by
- 112
- References
- 6
- FWCI
- 4.37
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.